BodyMedia

Nearly a year after announcing its direct-to-consumer fitness tracker AmpStrip -- and after raising more than $500,000 on Indiegogo for it -- Fitlinxx has announced that it will not be developing AmpStrip as a fitness tracker, but rather as a medical device.

Some 80 percent of people were more motivated to manage their health after using an activity tracker, according to a randomized control trial from March 2014 of 600 patients who are pre-diabetic and morbidly obese.

Jawbone UP2 After a string of lawsuits that Jawbone has filed against Fitbit, the latter has filed one of its own, suing Jawbone and its subsidiary, BodyMedia, in Delaware District Court, for alleged patent infringement.

BodyMedia's patents, now owned by Jawbone, are at the heart of the new suit.

It's that time of year again when all the major activity tracking device makers are announcing their next generation devices.

This year has proven to be an eventful one for fitness wearables-maker Jawbone, which for the past few weeks has been the subject of acquisition rumors, according to a number of sources.